Small Animal Imaging In Vivo Market Report
First published: 07 October 2024 | Last updated: 28 May 2026 | Report Code: small-animal-imaging-in-vivo
Small Animal Imaging In Vivo Market — USD 1.5 billion in 2023, Growing to USD 2.95B by 2033 at 6.8% CAGR
This report provides an insightful analysis of the Small Animal Imaging In Vivo market from 2023 to 2033, highlighting key trends, market size, CAGR, segmentation, regional insights, and the industry's future outlook.
Key Takeaways
- Global market value rises from $1.50 Billion in 2023 to $2.95 Billion in 2033, reflecting a 6.8% CAGR over 2023 to 2033.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- North America is the largest region, expanding from $0.56 Billion in 2023 to $1.09 Billion in 2033.
- Latin America records the highest implied regional growth at 7.70% CAGR, increasing from $0.1 Billion to $0.21 Billion.
- Europe grows from $0.41 Billion in 2023 to $0.81 Billion in 2033, supported by academic and clinical research investments.
- Key vendors include Bruker Corporation, PerkinElmer, Inc., Fujifilm VisualSonics and Siemens Healthineers, focusing on modality advancements.
Small Animal Imaging In Vivo Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. This report examines the Small Animal Imaging In Vivo market from 2023 to 2033, where value increases from $1.50 Billion to $2.95 Billion at a 6.8% CAGR. Growth is driven by rising preclinical activity, broader adoption of noninvasive modalities and continued investment in imaging platforms. Academic research institutes, pharmaceutical firms and CROs are prominent end users, while technologies such as MicroCT, MRI and optical imaging remain central. Regional patterns show North America as the largest market and Latin America recording the highest implied growth rate of 7.70%. Major suppliers—Bruker Corporation, PerkinElmer, Inc., Fujifilm VisualSonics and Siemens Healthineers—are advancing instrument performance and workflow integration. The report outlines market segmentation by technology, application and animal model, and highlights regulatory, funding and innovation trends that influence procurement and deployment decisions across preclinical settings.
Key Growth Drivers
- Increased funding and activity in preclinical and drug discovery programs expand demand for in vivo imaging solutions.
- Advances in imaging modalities and integration of sophisticated analytical workflows improve data quality and utility.
- Wider adoption of noninvasive techniques reduces study timelines and supports longitudinal research.
- Academic institutions and pharmaceutical companies continue to invest in research infrastructure, driving equipment purchases.
- Contract research organizations expand service offerings, creating consistent demand for preclinical imaging platforms.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $2.95 Billion |
| Top Companies | Bruker Corporation, PerkinElmer, Inc., Fujifilm VisualSonics, Siemens Healthineers |
| Published Date | 07 October 2024 |
| Last Modified Date | 28 May 2026 |
Small Animal Imaging In Vivo Market Overview
Customize Small Animal Imaging In Vivo Market Report market research report
- ✔ Get in-depth analysis of Small Animal Imaging In Vivo market size, growth, and forecasts.
- ✔ Understand Small Animal Imaging In Vivo's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Small Animal Imaging In Vivo
What is the Market Size & CAGR of Small Animal Imaging In Vivo Market Report market in 2023?
Small Animal Imaging In Vivo Industry Analysis
Small Animal Imaging In Vivo Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Small Animal Imaging In Vivo Market Report Market Analysis Report by Region
Europe Small Animal Imaging In Vivo Market Report:
Europe grows from $0.41 Billion in 2023 to $0.81 Billion in 2033. Funding for translational studies, collaborative research networks and investments in imaging platforms bolster regional adoption among universities and industry.Asia Pacific Small Animal Imaging In Vivo Market Report:
Asia Pacific grows from $0.29 Billion in 2023 to $0.57 Billion in 2033. Growth drivers include increasing drug discovery activities, rising research expenditures and expanding capabilities within regional CROs and academic centers.North America Small Animal Imaging In Vivo Market Report:
North America is largest regional market, rising from $0.56 Billion in 2023 to $1.09 Billion in 2033. Regional growth is supported by strong research infrastructure, substantial preclinical program activity and procurement by academic and commercial research organizations.South America Small Animal Imaging In Vivo Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.1 Billion in 2023 to $0.21 Billion in 2033. The region is noted as the fastest-growing with an implied 7.70% CAGR, supported by expanding research initiatives and growing investments in preclinical infrastructure.Middle East & Africa Small Animal Imaging In Vivo Market Report:
Middle East and Africa grows from $0.14 Billion in 2023 to $0.28 Billion in 2033. Adoption is influenced by targeted research funding, infrastructure development and growing clinical and academic interest in preclinical imaging.Tell us your focus area and get a customized research report.
Research Methodology
Small Animal Imaging In Vivo Market Analysis By Technology
In the technology segment, Micro Computed Tomography (MicroCT) holds the largest market share, accounting for approximately 68.78% in 2023, with projections to continue leading through 2033 with a similar share. Other technologies such as Magnetic Resonance Imaging (MRI) and Optical Imaging also remain relevant, serving specialized applications requiring precision and non-invasiveness.
Small Animal Imaging In Vivo Market Analysis By Application
The oncology application dominates the Small Animal Imaging In Vivo market, representing about 54.1% of the market share in 2023, with expectations to rise as cancer research expands. Other significant applications include neurology and cardiology, highlighting the diverse use of imaging technologies in medical research.
Small Animal Imaging In Vivo Market Analysis By Animal Model
Mice are the most utilized animal model in the Small Animal Imaging In Vivo market, with a share of 68.78% in 2023. This preference is driven by their genetic and physiological similarities to humans, making them ideal for drug testing and biological research. Rats and other species are also considered, but to a lesser extent.
Small Animal Imaging In Vivo Market Analysis By End User
Academic research institutions lead the end-user segment of the Small Animal Imaging In Vivo market, capturing a substantial share of around 68.78% in 2023. Pharmaceutical companies and CROs also play significant roles, reflecting the collaborative nature of research and development in the industry.
Small Animal Imaging In Vivo Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Small Animal Imaging In Vivo Industry
Bruker Corporation:
A leader in preclinical imaging technologies, Bruker offers innovative imaging solutions, including MRI and MicroCT, for small animals and plays a key role in advancing in vivo imaging research.PerkinElmer, Inc.:
PerkinElmer specializes in molecular imaging and has a wide portfolio of instruments, reagents, and imaging solutions tailored for preclinical research, enhancing efficiency in drug development.Fujifilm VisualSonics:
A prominent provider of micro imaging solutions, focused on high-resolution ultrasound and photoacoustic imaging systems that meet the growing demand in research and preclinical studies.Siemens Healthineers:
Siemens is renowned for its advanced imaging technology and applications in both medical and preclinical fields, contributing significantly to the enhancement of imaging standards.We're grateful to work with incredible clients.
FAQs
What is the market size of the Small Animal Imaging In Vivo Market Report in 2023?
The market size in 2023 is $1.50 Billion as stated in the report, reflecting the baseline value for the 2023 to 2033 forecast period.
How big will the market be in 2033?
By 2033 the market is projected to reach $2.95 Billion, representing the end-point value for the 2023 to 2033 forecast timeline.
What is CAGR for the forecast period?
The compound annual growth rate for 2023 to 2033 is 6.8%, as reported for the market over the stated decade.
Which region is the fastest Growing in the Small Animal Imaging In Vivo Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.1 Billion in 2023 to $0.21 Billion in 2033, reflecting an implied 7.70% CAGR over the forecast period.
Why is Latin America notable in the regional analysis?
Latin America is the regional market region with an implied 7.70% CAGR, rising from $0.1 Billion in 2023 to $0.21 Billion in 2033.
Who are the top companies operating in this market?
Top companies listed include Bruker Corporation, PerkinElmer, Inc., Fujifilm VisualSonics and Siemens Healthineers as key equipment and solution providers.
How do end users influence market demand?
Academic research institutes, pharmaceutical companies and CROs drive demand through preclinical programs, infrastructure investments and outsourced study requirements.
What are the principal technology segments covered?
The report covers Micro Computed Tomography (MicroCT), Magnetic Resonance Imaging (MRI) and Optical Imaging as primary technology categories.